Immune mechanisms have been increasingly recognized in the pathogenesis of hippocampal sclerosis (HS), but infiltration of cytotoxic T-cells and its pathological significance in patients with HS has not been explored. We examined 30 cases of surgically resected hippocampi, including 16 International League Against Epilepsy (ILAE) type 1, 9 ILAE type 2, 1 ILAE type 3 HS, and 4 ILAE No-HS, as well as 6 autopsy No-HS hippocampi. The HS hippocampi showed sparse to scattered CD8-positive T-cells, rare CD4-positive T-cells, and a modest increase in CD68-positive microglia/macrophages, which were significantly more numerous than those in the No-HS controls. The infiltration of CD8-positive T-cells was significantly greater in the CA1 subfield than other subfields of type 1 and type 2 HS. The numbers of CD8-positive T-cells positively correlated with those of CD4-positive T-cells; there was a lower ratio of CD4/CD8-positive T-cells. There were positive correlations between these cells and scores of neuronal loss but no significant correlation between the infiltration of these cells and epilepsy disease duration or age of epilepsy onset. These findings suggest that an autoimmune process may be involved in the pathogenesis of HS and infiltration of immune cells, particularly CD8-positive cytotoxic T-cells, may contribute to neuronal loss in HS.
INTRODUCTION
Hippocampal sclerosis (HS) is the most common histopathological finding in patients with medically refractory temporal lobe epilepsy (TLE) (1, 2) . The histopathological hallmark of HS is segmental neuronal cell loss, which may affect any sector of cornu ammonis (CA) and be associated with gliosis. Patients with HS are commonly resistant to anticonvulsant medication (3); and radiographically apparent HS is a strong predictor of successful epilepsy surgery (4) . The International League Against Epilepsy (ILAE) has recently published a consensus classification of HS in TLE that is designed to classify specific patterns of hippocampal neuronal loss and correlate subtypes with post-surgical outcome (1) . ILAE type 1 HS (the most common type of HS with severe neuronal loss and gliosis predominantly in CA1 and CA4 regions) is often associated with a history of initial precipitating injuries before age 5 years, early seizure onset, and favorable post-surgical seizure control. ILAE type 2 HS with CA1 predominant neuronal loss and ILAE type 3 HS with CA4 predominant neuronal loss are rarer and less systematically studied but may have less favorable outcomes.
The etiology of HS is controversial and assumed to be multifactorial (2) . A number of studies have suggested that most of the neuronal loss in HS occurs with a variety of the initial precipitating incidents, such as febrile seizures and closed head injury; thus, hippocampal neuron loss may be the "consequence" of repeated limbic seizures (5) . However, the mechanism(s) by which an initial precipitating incident eventually results in HS and epileptogenesis remain incompletely understood (6) . Some other studies have found associations between mesial TLE with HS (TLE-HS) and human leukocyte antigens (7) , as well as between TLE-HS and gluten sensitivity with the presence of anti-gliadin antibodies and positive immunogenetics (8) . Immune mechanisms have been increasingly identified in neurodegenerative and other neurological diseases including epilepsy (9, 10) . In patients with TLE-HS, inflammation and immune responses have been increasingly implicated as a potential underlying mechanism (2, 11, 12) . There is evidence of activation of both innate and adaptive immune responses in HS (12) (13) (14) . The innate immune response in TLE-HS involves astrocytes, neurons, and microglia, with upregulation of interleukin (IL)-1a and 1b, as well as other inflammatory proteins (15) (16) (17) (18) . Gene expression studies also suggest inflammatory pathway activation that is thought to be a driving force in disease progression (18) (19) (20) . Disruption of the blood-brain barrier (BBB), as demonstrated in the animal models of epilepsy, could potentially result in brain infiltration by circulating immune cells (14, 18, 21, 22) . Nevertheless, the adaptive immune response in TLE-HS is relatively less studied. A few mouse studies have demonstrated infiltration of CD4-positive and CD8-positive T-cells in the hippocampi of epileptic mice (14, 23) . One of those studies also noted the intraparenchymal infiltration of CD3-positive T-cells but not CD20-positive B-cells in 7 of 9 hippocampal tissue samples from HS patients (14) . A small case series examined the hippocampi of 4 patients with HS compared to 4 control subjects with No-HS; that study revealed no CD8-positive or CD4-positive lymphocytes in the hippocampi of control subjects but infiltrating CD8-positive and CD4-positive lymphocytes associated with diffusely upregulated intercellular adhesion molecule-1 in all the hippocampi of HS patients (24) . It remains unknown, however, whether T-lymphocytic infiltration is a ubiquitous finding in all patients with HS or just in distinct patient sub-groups with an inflammatory component. In the present study, we examined surgically resected hippocampi from a considerable number of HS patients who are grouped by the ILAE consensus classification of HS (1).
MATERIALS AND METHODS

Patients and Study Design
We received ethics approval from the local institutional Committee on Human Research to complete the study. Written informed consent was obtained in each case. This retrospective study included 30 consecutive cases of surgically resected hippocampi that were collected between 2008 and 2015 at the University of Alberta Hospital. These cases had no prior invasive electrode placement in the hippocampus. We excluded cases with concurrent CNS inflammatory/infectious diseases and/or positive antibody tests, as well as cases with insufficient hippocampal tissues for assessment. All patients included in this study had medically intractable epilepsy with the primary seizure pattern being complex partial seizures consistent with temporal lobe seizure onset. For subjects with concordant ictal clinical semiology, ictal and interictal surface electroencephalogram (EEG) epileptic activity and magnetic resonance imaging (MRI) evidence of mesial temporal sclerosis or other temporal lobe structural lesions, a decision to proceed to surgery was typically made without intracranial EEG/ video telemetry. For patients with discordant noninvasive investigations (in particular in the absence of MRI evidence of temporal lobe structural lesions), intracranial EEG/video evaluations were performed to confirm the epileptic focus. The patient clinical characteristics are shown in the Table. HS was diagnosed and subclassified according to the ILAE consensus classification of HS (1) . For comparison, we also examined 6 cases of autopsy hippocampal sections from the patients with no neurological diseases or only cerebral arteriosclerosis.
Histopathology and Immunohistochemistry
The surgical hippocampal specimens were formalinfixed, routinely processed, paraffin-embedded, sectioned at 5 mm, and stained with hematoxylin and eosin (H&E), and Luxol fast blue (LFB, with H&E), and by immunohistochemical methods. The H&E-stained slides (with and without LFB) were examined for morphological features. Immunohistochemistry was performed on tissue sections using the EnVision FLEX Mini Kit, High pH (Autostainer/Autostainer Plus; Dako, Carpinteria, CA), detection system after the tissue was deparaffinized and rehydrated according to the standard protocol. Antibodies to the following were used: Neu-N (A60, Millipore, Billerica, MA), GFAP (Z0334, Dako), CD68K (KP1, Dako), CD8 (C8/144B, Dako), and CD4 (4B12, Vector Laboratories, Burlingame, CA).
The morphological and immunohistochemical features of each case/section were reviewed and assessed. In each hippocampal subfield, the numbers of CD8-positive cytotoxic T-cells (CTL) and CD4-positive T-cells were then counted consistently by a neuropathologist in a microscopic high-power field ([HPF], original magnification 400Â; 0.16 mm 2 ; profile counts where a profile is defined as an immunopositive cell seen in a microscopic slide) for 10 consecutive HPFs. For the hippocampal subfields with more than 10 HPFs, 10 consecutive HPFs were chosen in the plane and area with the highest frequency of immunopositive cells. The frequencies of CD68-positive microglia were scored using the following scheme: 0, no or minimal increase (compared to the normal-appearing brain tissue with resting microglia); 1, moderate increase, (without morphological activation); 2, severe increase, (with or without morphological activation). Morphological activation of CD68-positive cells was defined as the change in cytoplasmic ramification to an amoeboid morphology. Intravascular positive cells were not counted. We did not separate counts of perivascular and intraparenchymal positive cells for 2 reasons. First, the pathophysiology of the hippocampal blood vessels, i.e. because they are mostly post-capillary venules with more trafficking of inflammatory cells across the endothelial barrier, and second, for practical accuracy because some positive cells may appear to be intraparenchymal in 1 section but possibly and virtually perivascular in its adjacent section. Neuronal loss was assessed by the ILAE scoring system (1), in which the neuronal cell loss, (based on Neu-N immunostaining) is defined as follows: 0 ¼ no obvious neuronal loss or moderate astrogliosis only; 1 ¼ moderate neuronal loss and gliosis (based on GFAP immunostaining); 2 ¼ severe neuronal loss (majority of neurons lost) and fibrillary astrogliosis. Astrocytic gliosis was also examined on the GFAP immunostaining sections.
Statistical Analysis
Nonparametric statistical analysis was performed using GraphPad Prism 7 software. The Kruskal-Wallis test was first used to assess the difference in variables among several groups, followed by the Mann-Whitney U-test (2-tailed) for further comparisons between 2 groups. The Pearson Product Moment correlation coefficient was employed to test the association between 2 variables. P values < 0.05 were regarded as significant. (Fig. 1A, B) . Type 1 HS showed marked neuronal loss in all the hippocampal subfields ( Fig 1C) associated with astrocytic gliosis (Fig. 1D) . Type 2 HS exhibited neuronal loss predominantly in CA1 ( Fig. 2A, B) , associated with astrocytic gliosis. Type 3 HS displayed the neuronal loss predominantly in CA4 associated with astrocytic gliosis. The neuronal loss was highlighted by Neu-N immunostaining. In these HS cases, GFAPimmunoreactive astrocytic gliosis was prominent but relatively diffuse and difficult to quantify its differences among the hippocampal subfields (Fig. 1D) . No other hippocampal disease (including primary inflammation, Table) was found in these cases; this was consistent with the original pathological diagnosis of these surgical and autopsy resections. In addition, the hippocampal subfields exhibited varying degrees of infiltration of lymphocytes that were immunopositive for CD8 or CD4 and microglia/macrophages that were immunopositive for CD68.
CD8-Positive Cytotoxic T-Cells
The hippocampi of HS cases showed sparse to scattered CD8-positive cells with lymphocyte morphology (Figs. 1, 2) . The frequencies of CD8-positive cells varied among the subfields depending on the HS types (Fig. 3A) . Sixteen type 1 HS showed significantly greater infiltration of CD8-positive cells 
CD4-Positive T-Cells
CD4-positive cells with lymphocyte morphology were rare in all the hippocampi overall (Figs. 1K, 2H, 3B 
CD68-Positive Microglia/Macrophages
The surgically resected and autopsy hippocampi showed varying frequencies of CD68-positive microglia/macrophages. A modest increase in the frequency of CD68-positive cells was seen in HS (Figs. 1L, 2I, 3C ). There were sparse to scat- Table) demonstrates marked neuronal loss in the hippocampal subfields (C, Neu-N immunostain; the inset exhibiting other tissues of this hippocampal specimen), associated with relatively diffuse astrocytic gliosis (D, GFAP immunostain), and the hippocampus (E, Luxol fast blue stain; 7 rectangles indicating the areas of F-L) containing sparse to scattered CD8-positive cytotoxic T-cells in CA1 (F), CA2 (G), CA3 (H), CA4 (I), and DG (J), rare CD4-positive T-cells (K) as well as modestly increased frequency of CD68-positive microglia/macrophages (L). Original magnifications, 15Â (A-E) and 400Â (F-L). HS, hippocampal sclerosis; CA, cornu ammonis; DG, dentate gyrus.
Clinical Correlations With the Infiltration of Immune Cells in HS
The patients with TLE-HS were further analyzed for correlation of clinical variables with the infiltration of immune cells. The 26 patients with TLE-HS ranged in age from 4 to 76 years, with a median of 34 years at the time of surgical procedure. In 23 of these 26 patients with TLE-HS ( Table) , the ages of epilepsy onset were known and ranging from 0.1 to 41 years with the median of 18 years; the duration of epilepsy between the age of onset and surgery ranged from 3 to 49 years with the median of 13 years. In these 23 patients (given the infiltration of immune cells predominantly in the CA1 subfield), we examined correlations of immune cells in CA1 with the duration of epilepsy disease and the age of onset. There were no significant correlations between the duration of disease and the number of CD8-positive cells in CA1 (r ¼ À0. 
DISCUSSION
This study reveals ubiquitous but variable immune cell infiltrates in HS specimens obtained from patients without prior depth electrode implantation in the hippocampus. Further to the previous small series (24), our study shows sparse to scattered CD8-positive CTL in all cases of HS, as well as rare Table) shows the hippocampus (A, Luxol fast blue stain) with marked neuronal loss predominantly in CA1 (C, Neu-N immunostain; 7 rectangles indicating the areas of C-I), sparse to scattered CD8-positive cytotoxic T-cells in CA1 (C), CA2 (D), CA3 (E), CA4 (F), and DG (G), rare CD4-positive Tcells (H) as well as modestly increased frequency of CD68-positive microglia/macrophages (I). Original magnifications, 15Â (A, B) and 400Â (C-I). HS, hippocampal sclerosis; CA, cornu ammonis; DG, dentate gyrus.
CD4-positive T-cells and modest increase in CD68-positive microglia/macrophages in HS specimens. Furthermore, we show for the first time that there are positive correlations between the infiltration of immune cells and neuronal loss in HS. These findings suggest that the infiltration of immune cells, particularly of CD8-positive CTL, may play an important role in the pathogenesis of HS.
Both autoreactive CD8-positive and CD4-positive Tcell responses play crucial roles in the CNS diseases (25) . Once the adaptive immune response is initiated, circulating Tcells need to enter the brain to exert beneficial or deleterious effects. The mechanisms of CD8-positive and CD4-positive T-cell infiltration into the brain differ (21, 25) . CD8-positive and CD4-positive T-cells may express different adhesion molecules when they adhere the brain venules to traverse the BBB. Unlike CD4-positive T-cells, antigen specificity is a factor that governs CD8-positive T-cell infiltration into the brain. Selective trafficking of antigen-specific CD8-positive T-cells into the brain has been found to be dependent on cerebral vascular endothelial cell luminal surface expression of major histocompatibility complex class I molecules but independent of antigen presentation of perivascular macrophages (21) . The difference between CD8-positive and CD4-positive T-cell trafficking may account for the preferential recruitment of CD8-positive CTL into the CNS in a number of CNS inflammatory diseases such as multiple sclerosis (25) . It has been noted that CD8-positive T-cells outnumber CD4-positive T-cells in those diseases (26) . In the present study, the findings of more CD8-positive but rare CD4-positive cell infiltration in HS may be attributed to the underlying disease process and/or different mechanisms of their infiltration into the brain; the infiltration of predominantly CD8-positive CTL with a lower ratio of CD4-positive/CD8-positive T-cells (approximately 1/10, Fig. 3A vs B) may suggest an autoimmune process in HS (27) .
CD8-positive CTL are instrumental in response to various inflammatory neurological conditions (21, 25) . CD8-positive CTL induced neuropathology can be mediated directly by CNS antigen-specific CD8-positive CTL or indirectly as a result of bystander damage by co-infiltrating CD8-positive CTL with irrelevant antigen specificities (21, 28) . Although bystander CD8-positive CTL alone failed to cause tissue injury, they could be sufficient to induce immune-mediated neuropathology (28) . A number of cytokines including IL-1b and IL-1R are rapidly upregulated in the brain after seizures (18, 29, 30) ; IL-1b, IL-6, and tumor necrosis factor are increased in microglia and astrocytes in epileptic tissue and may lead to recruitment of adaptive immune system cells (11, 12, 31) . Cytokines released by perivascular microglia and astrocytes contribute to the BBB dysfunction in epilepsy (12) . Microvascular alterations including spine-like protrusions and disruptions have been noted in the patient sclerotic hippocampi particularly in the CA1 subfield, which may relate to the pathogenesis of HS (32) . The dysfunction of BBB and increased expression of proinflammatory cytokines underscore the activation of adaptive immune responses (14, (33) (34) (35) . CD8-positive CTL and other circulating immune cells across the disrupted BBB infiltrate the brain to exert their effects (9, 13, 14, 21, 22) . In the present study, the finding of a positive correlation between the infiltration of CD8-positive CTL and neuronal loss implies that the infiltration of CD8-positive CTL is associated with the neuronal loss and likely more deleterious than beneficial to the neuronal population in HS. In the present study, it is unclear if the infiltration of CD8-positive CTL in HS is mediated by antigen-specific or bystander responses, i.e. the target antigen of CD8-positive CTL is unknown (12, 36) . Another limitation of the present study is that no experiment was performed to show the causal role of T-cells in HS. Although we find positive correlations between T-cell infiltration and neuronal loss in HS, further studies are needed to identify if there are specific and/or nonspecific antigens in HS, and to prove the causal role of T-cells in HS.
We found greater infiltration of CD8-positive CTL in CA1 than other hippocampal subfields, positively correlated with the neuronal loss, which is consistent with the conclusion of previous studies indicating significantly greater neuronal loss in CA1 than other hippocampal subfields in HS (37) . Although the recent ILAE classification of HS segregates HS into the subtypes, ILAE type 1 HS with the neuronal loss most severe in CA1 accounts for approximately 60%-80% and type 2 HS with predominant CA1 neuronal loss accounts for approximately 5%-10% of all HS but type 3 HS with predominant CA4 neuronal loss is rare in TLE surgical cases (1) . The present study comprises 16 cases of type 1 HS and 9 cases of type 2 (including 2 relatively mild) HS but only 1 case of type 3 HS, which proportion is similar to the prevalence of HS sub- types and likely contributory to the greater infiltration of CD8-positive CTL in correlation with greater neuronal loss in CA1 than other subfields. While there is no evidence that ILAE type 2 or type 3 HS progresses to type 1 HS over time (2) , these HS subtypes may have different causes in addition to different pathological patterns and outcomes (38) . In the present study, our observation suggests that CD8-positive CTL may be involved in the pathogenesis of neuronal loss at least in the common ILAE types of HS.
Although some clinical variables might have affected immune cell infiltration in this study, our further analysis revealed a wide range in the age of epilepsy onset and in the duration of disease in patients with TLE-HS. Furthermore, we found no significant correlation between immune cell infiltration in CA1 and the duration of disease or age of epilepsy onset. Of particular note is that the patients in the present study had prolonged epilepsy disease durations (median of 13 years; minimum of 3 years). Despite the chronicity of their epilepsy, the patients underwent surgical resections because of ongoing seizure activity, which may be particularly related to the infiltration of immune cells in the present study.
Neuropathological examination of surgical specimens from patients with TLE-HS has provided evidence of a sustained activation of the innate immune response, i.e. both astrocytes and microglia/macrophages (12, 15, 16, 18, 19) . There is a crosstalk between CD68-positive microglia/macrophages and CD8-positive CTL in brain inflammation (39) that may occur via antigen-dependent or antigen-independent pathways. Nevertheless, as aforementioned, selective traffic of antigen-specific CD8-positive T-cells into the native brain appears to be independent of antigen presentation of perivascular microglia/macrophages (21) . A postmortem study of 13 cortical regions from both left and right hemispheres of 9 patients with HS and 4 non-epilepsy controls found that CD68-positive microglia/macrophages were not restricted to the hippocampi but were widespread, even without lateralization to the side of classic HS (40) . In that study, CD68-positive microglia/macrophages were significantly more abundant in the subcortical white matter compared to the cortex in epilepsy cases, and more in the white matter of classic HS compared to non-epilepsy control cases, but there was no significant difference in CD68-positive microglia/macrophages between left and right hemispheres in 4 unilateral classic HS. GFAP-positive astrocytic gliosis was also similarly widespread with more in the subcortical white matter in epilepsy cases. These findings suggest that pathological changes in CD68-positive microglia/macrophages and GFAP-positive astrocytic gliosis may be nonspecific and spread to the neocortical regions without significant neuronal loss in patients with HS. In the present study, a modest increase in CD8-positive microglia/macrophages appears to have a different pattern of distribution in the hippocampi with no CA1 predominance, in contrast to that of CD8-positive cell infiltration with the CA1 predominance. Characterization of the interaction between CD68-positive microglia/macrophages and CD8-positive CTL needs further study.
In summary, this study reveals the infiltration of immune cells with positive correlations with the neuronal loss in the hippocampi of patients with HS. The infiltration is composed predominantly of CD8-positive CTL with rare CD4-positive T-cells and a lower ratio of CD4-positive/CD8-positive T-cells. Given the cytotoxic functions CD8-positive T-cells, this study suggests that they may contribute to the neuronal loss in HS. Further studies are warranted to determine whether there are specific or nonspecific antigens in the hippocampal tissues of HS patients, and to investigate whether there might benefit from immunosuppressive or immunomodulatory therapies (9, 26) .
